|
US20020032160A1
(en)
*
|
1995-02-24 |
2002-03-14 |
Nyce Jonathan W. |
Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels
|
|
US5660835A
(en)
*
|
1995-02-24 |
1997-08-26 |
East Carolina University |
Method of treating adenosine depletion
|
|
US6653297B1
(en)
*
|
1997-07-03 |
2003-11-25 |
Medical College Of Hampton Roads |
Control of selective estrogen receptor modulators
|
|
EP0943333A1
(de)
*
|
1998-03-18 |
1999-09-22 |
S.W. Patentverwertungs GmbH |
Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen
|
|
GB9923076D0
(en)
|
1999-09-29 |
1999-12-01 |
Phytopharm Plc |
Sapogenin derivatives and their use
|
|
JP2002522462A
(ja)
*
|
1998-08-13 |
2002-07-23 |
ハダシット・メディカル・リサーチ・サービシイズ・アンド・ディベロプメント・カンパニー・リミテッド |
組織外傷に関連した病原プロセスの阻害
|
|
BR0110079A
(pt)
*
|
2000-04-12 |
2002-12-31 |
Novartis Ag |
Combinação de compostos orgânicos
|
|
AU6800101A
(en)
*
|
2000-07-05 |
2002-01-14 |
Astrazeneca Ab |
Pharmaceutical combination of an anti-androgen and anastrozole for providing an antiandrogenic effect and aromatase inhibition
|
|
AU2001271162A1
(en)
*
|
2000-07-05 |
2002-01-14 |
Astrazeneca Ab |
Pharmaceutical combination of an anti-androgen and letrozole for providing an anit-androgenic effect and aromatase inhibition
|
|
WO2002002099A1
(en)
*
|
2000-07-05 |
2002-01-10 |
Astrazeneca Ab |
Pharmaceutical combination of an anti-androgen and tamoxifen for providing an anti-androgenic effect and aromatase inhibition
|
|
JP2004269356A
(ja)
*
|
2000-12-27 |
2004-09-30 |
Ajinomoto Co Inc |
創傷部癒着防止剤
|
|
US6559177B2
(en)
|
2001-04-19 |
2003-05-06 |
Wyeth |
5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents
|
|
AU2002303427A1
(en)
*
|
2001-04-24 |
2002-11-05 |
East Carolina University |
Compositions and formulations with a non-glucocorticoid steroid and/or a ubiquinone and kit for treatment of respiratory and lung disease
|
|
AU2002303425A1
(en)
*
|
2001-04-24 |
2002-11-05 |
Epigenesis Pharmaceuticals, Inc. |
Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
|
|
US6589980B2
(en)
|
2001-05-17 |
2003-07-08 |
Wyeth |
Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
|
|
AU2003224649B2
(en)
|
2002-03-04 |
2006-09-07 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. |
Sustained release drug formulations containing a carrier peptide
|
|
BR0311883A
(pt)
*
|
2002-06-17 |
2005-04-05 |
Epigenesis Pharmaceuticals Llc |
Recipiente selado, kit, e, métodos para a profilaxia ou tratamento da asma, para a profilaxia ou tratamento da doença pulmonar obstrutiva crÈnica, para a redução ou exaustão da adenosina em um tecido do paciente e para profilaxia ou tratamento de um distúrbio ou condição associada com nìveis altos de adenosina ou sensibilidade à adenosina em um tecido do paciente
|
|
US7405207B2
(en)
|
2002-06-17 |
2008-07-29 |
Epigenesis Pharmaceuticals, Inc. |
Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
|
|
ATE488240T1
(de)
*
|
2003-04-18 |
2010-12-15 |
Advanced Medicine Res Inst |
Mittel zur behanldung von krankheiten zur aufbringung auf das auge
|
|
DE602004004698T2
(de)
*
|
2003-07-29 |
2007-11-22 |
Acme S.R.L. |
Verwendung von Stanozolol zur Herstellung von entzündungshemmenden und antidegenerativen Arzneimitteln
|
|
US20090274676A1
(en)
*
|
2003-07-31 |
2009-11-05 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050038004A1
(en)
*
|
2003-07-31 |
2005-02-17 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026880A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026883A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20090285899A1
(en)
*
|
2003-07-31 |
2009-11-19 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026881A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026884A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050101545A1
(en)
*
|
2003-07-31 |
2005-05-12 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050085430A1
(en)
*
|
2003-07-31 |
2005-04-21 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050113318A1
(en)
*
|
2003-07-31 |
2005-05-26 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026890A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20090263381A1
(en)
*
|
2003-07-31 |
2009-10-22 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20090285900A1
(en)
*
|
2003-07-31 |
2009-11-19 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026879A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026882A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20110209699A1
(en)
*
|
2003-07-31 |
2011-09-01 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050043282A1
(en)
*
|
2003-07-31 |
2005-02-24 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026848A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
|
|
EP1765336A4
(en)
*
|
2004-06-25 |
2010-03-10 |
Univ Johns Hopkins |
ANGIOGENESIS INHIBITORS
|
|
EP1815346A4
(en)
*
|
2004-09-21 |
2010-12-22 |
Diapedia L L C |
METHOD FOR DESIGNING AND MANUFACTURING INNER INSOLES
|
|
US20060189909A1
(en)
*
|
2005-02-24 |
2006-08-24 |
Hurley Timothy B |
Load relieving wound dressing
|
|
US20070009470A1
(en)
*
|
2005-07-06 |
2007-01-11 |
Kin Jung |
Topical/on-the-skin estrogen cream, lotion, ointment, hair tonic, shampoo and wound healing powder
|
|
ITMI20051516A1
(it)
|
2005-08-02 |
2007-02-03 |
Prime Europ Therapeuticals |
Derivati 17 alfa-sostituti dell'estradiolo ad attivita' cicatrizzante
|
|
US20070163147A1
(en)
*
|
2005-09-21 |
2007-07-19 |
Cavanagh Peter R |
Method for Design and Manufacture of Insoles
|
|
WO2008060622A2
(en)
|
2006-11-15 |
2008-05-22 |
Coda Therapeutics, Inc. |
Improved methods and compositions for wound healing
|
|
US20080132475A1
(en)
*
|
2006-12-05 |
2008-06-05 |
Charles Gerald Connor |
Treatment for dry eye
|
|
WO2008078073A1
(en)
*
|
2006-12-23 |
2008-07-03 |
Renovo Limited |
Medicaments and methods comprising a compound that promotes oestrogenic activity for wound healing
|
|
GB0625962D0
(en)
*
|
2006-12-23 |
2007-02-07 |
Renovo Ltd |
Medicaments and methods for wound healing
|
|
WO2008078074A1
(en)
*
|
2006-12-23 |
2008-07-03 |
Renovo Limited |
Promotion of wound contraction with a compound that promotes oestrogenic activity
|
|
US20100016264A1
(en)
*
|
2007-12-05 |
2010-01-21 |
Connor Charles G |
Treatment for dry eye using testosterone and progestagen
|
|
GB0724231D0
(en)
*
|
2007-12-12 |
2008-01-30 |
Renono Ltd |
Methods for inhibiting scarring
|
|
US20110217313A1
(en)
*
|
2007-12-21 |
2011-09-08 |
Becker David L |
Treatment of orthopedic conditions
|
|
EP2234656A2
(en)
*
|
2007-12-21 |
2010-10-06 |
Coda Therapeutics, Inc. |
Improved medical devices
|
|
US10279007B2
(en)
|
2010-11-15 |
2019-05-07 |
Oxygenetix Institute, Inc. |
Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs
|
|
KR101966293B1
(ko)
*
|
2011-09-13 |
2019-04-08 |
브라이엄 영 유니버시티 |
손상조직 치유용 제품
|
|
CA2856520C
(en)
|
2011-11-23 |
2021-04-06 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
CN104661672B
(zh)
|
2012-05-11 |
2017-03-08 |
珍白斯凯尔有限公司 |
用于预防或治疗败血症的组合物
|
|
KR20210025132A
(ko)
|
2012-05-11 |
2021-03-08 |
주식회사 젬백스앤카엘 |
항염증 활성을 갖는 펩티드 및 이를 포함하는 조성물
|
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US10967000B2
(en)
|
2012-07-11 |
2021-04-06 |
Gemvax & Kael Co., Ltd. |
Cell-penetrating peptide, conjugate comprising same and composition comprising same
|
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
AU2014275610B2
(en)
|
2013-06-07 |
2018-06-14 |
Gemvax & Kael Co., Ltd. |
Biological markers useful in cancer immunotherapy
|
|
TWI539960B
(zh)
|
2013-06-21 |
2016-07-01 |
凱爾傑姆維克斯有限公司 |
激素分泌調節劑、包括其的組成物以及其用途
|
|
KR102494803B1
(ko)
|
2013-11-22 |
2023-02-06 |
주식회사 젬백스앤카엘 |
혈관 신생 억제 활성을 가지는 펩티드 및 이를 포함하는 조성물
|
|
CN105939723B
(zh)
|
2013-12-17 |
2020-02-28 |
珍白斯凯尔有限公司 |
前列腺癌治疗用组合物
|
|
JP6420459B2
(ja)
|
2014-04-11 |
2018-11-07 |
ジェムバックス アンド カエル カンパニー，リミティド |
線維症抑制活性を有するペプチド及びこれを含む組成物
|
|
EP3138399B1
(en)
|
2014-04-30 |
2023-09-06 |
Gemvax & Kael Co., Ltd. |
Composition for organ, tissue, or cell transplantation, kit, and transplantation method
|
|
MX2016014281A
(es)
|
2014-05-22 |
2017-02-22 |
Therapeuticsmd Inc |
Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
|
|
AU2015305269B2
(en)
|
2014-08-22 |
2021-12-23 |
Auckland Uniservices Limited |
Channel modulators
|
|
KR102413243B1
(ko)
|
2014-12-23 |
2022-06-27 |
주식회사 젬백스앤카엘 |
안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물
|
|
EP3263122B1
(en)
|
2015-02-27 |
2020-05-06 |
Gemvax & Kael Co., Ltd. |
Peptide for preventing hearing loss, and composition comprising same
|
|
JP6923453B2
(ja)
|
2015-07-02 |
2021-08-18 |
ジェムバックス アンド カエル カンパニー，リミティド |
抗ウイルス活性効能を有するペプチド及びこれを含む組成物
|
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
|
WO2017173044A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
|
MX2018011705A
(es)
|
2016-04-01 |
2019-06-10 |
Therapeuticsmd Inc |
Composicion farmaceutica de hormona esteroide.
|
|
JP7114481B2
(ja)
|
2016-04-07 |
2022-08-08 |
ジェムバックス アンド カエル カンパニー，リミティド |
テロメラーゼ活性の増加及びテロメアの延長の効能を有するペプチド、及びこれを含む組成物
|
|
WO2020160225A1
(en)
*
|
2019-01-30 |
2020-08-06 |
Ohio State Innovation Foundation |
ESTROGEN RECEPTOR BETA (ERβ) AGONISTS FOR THE TREATMENT OF FIBROTIC CONDITIONS
|
|
KR102842907B1
(ko)
*
|
2019-09-27 |
2025-08-07 |
(주)아모레퍼시픽 |
신규 진세노사이드를 포함하는 갱년기 증상의 예방 또는 개선용 조성물
|